PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsIntermittent claudication
MeSH D007383 - intermittent claudication
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012816:Signs and symptoms
0 Companies
0 Drugs
Success rate
D058729:Peripheral arterial disease
4 Companies
2 Drugs
$
Success rate
D007383: 
Intermittent claudication
17 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCilostazol Cilostazol  2005-03-01   
Rising PharmaceuticalsCilostazol Cilostazol  2006-04-20   
Pentoxifylline Pentoxifylline  1997-07-08   
Bausch Health CompaniesPentoxifylline Pentoxifylline  1998-07-20   
ApotexCilostazol Cilostazol  2004-12-10   
Pentoxifylline Pentoxifylline  1999-06-09   
Chartwell PharmaceuticalsCilostazol Cilostazol  2012-09-24   
Impax LaboratoriesPentoxifylline Pentoxifylline  1999-08-10   
Nostrum LaboratoriesCilostazol Cilostazol  2009-09-28   
ANI PharmaceuticalsPentoxifylline Pentoxifylline  1997-07-09   
Validus PharmaceuticalsPentoxifylline Trental  1984-08-30   
Upsher-Smith LaboratoriesPentoxifylline Pentoxil  1999-03-31   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
40%
2/5
Phase 2
40%
4/10
Phase 3
29%
4/14
Approved: 2Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cilostazol
Otsuka
Cilostazol,
Tartrate
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use